Paychex, Inc. filings document formal disclosures for its human capital management business, including quarterly operating results furnished on Form 8-K, credit facility amendments, capital-return authorizations, and governance changes involving directors and senior officers.
The company's proxy materials and annual-meeting reports address board elections, executive compensation votes, auditor ratification, committee matters, and stockholder voting outcomes. Its filings also describe common-stock repurchase authority, revolving credit facilities, covenant changes, and formal reporting for payroll, HCM, HR Solutions, PEO, ASO, benefits, retirement, and insurance services.
Paychex, Inc. is identified as the issuer in a Rule 144 notice listing 21,890 common shares for sale for the account of B. Thomas Golisano, identified as a 10% shareholder. Merrill Lynch is named as broker; the approximate sale date is October 22, 2026, and the aggregate market value is $2,547,339. The notice reports 357,600,000 shares outstanding.
Paychex Inc. (PAYX) President and CEO John B. Gibson had 409 common shares withheld on October 19, 2026, to satisfy tax-withholding obligations arising from the lapse of restrictions on restricted stock units. The reported per-share price was $110.75, and Gibson directly held 80,957 common shares after the transaction. The report also lists direct stock options covering 31,653 underlying common shares at a $69.54 exercise price, expiring July 10, 2028, and 96,971 underlying shares at a $110.00 exercise price, expiring July 14, 2036.
Paychex, Inc. 10% shareholder Thomas B. Golisano is named in a notice for a proposed sale of 14,747 common shares through Merrill Lynch, with an approximate sale date of October 20, 2026. During the preceding three months, B. Thomas Golisano Revocable Living Trust reported sales of 562,635 shares on September 28, 2026; 295,857 shares on October 19, 2026; and 14,747 shares on October 20, 2026.
Paychex, Inc. (PAYX) is named in a Form 144 notice listing 295,857 common shares for sale for B. Thomas Golisano, a 10% shareholder, at an aggregate market value of $32,674,447 and with an approximate sale date of October 19, 2026. The notice also lists sales by the B. Thomas Golisano Revocable Living Trust: 562,635 shares on September 28, 2026, for gross proceeds of $56,212,863, and 295,857 shares on October 19, 2026, for gross proceeds of $32,674,447. Paychex shares outstanding are stated as 357,600,000. Harrison Wright signed the notice.
Paychex, Inc. reported that all ten director nominees—Martin Mucci, Thomas F. Bonadio, Joseph G. Doody, John B. Gibson, J. Michael Hansen, Pamela A. Joseph, Theresa M. Payton, Kevin A. Price, Joseph M. Tucci and Joseph M. Velli—were elected at its October 15, 2026 annual meeting. The non-binding advisory vote on named executive officer compensation was approved, with 281,426,667 votes for; PricewaterhouseCoopers LLP’s selection as independent registered public accounting firm for fiscal year 2027 was ratified, with 321,717,754 votes for.
A stockholder proposal regarding an attainable stockholder right to call a special meeting was not approved: 142,899,210 votes for and 146,541,000 against.
Paychex director Pamela A. Joseph was awarded 970 restricted stock units on October 15, 2026, subject to vesting; her reported direct common-stock holdings afterward were 12,740 shares. She also received an award of 4,040 stock options with an exercise price of $110.78 per share. The options are exercisable on October 15, 2027, and expire October 14, 2036.
Her reported option holdings also included options covering 10,801 common shares at a $70.37 exercise price, expiring July 11, 2028, and options covering 7,929 common shares at an $85.33 exercise price, expiring July 10, 2029.
Paychex Inc. (PAYX) director Joseph M. Velli reported selling 7,839 common shares at $107.68 per share on October 14, 2026. On October 15, he received awards of 4,040 stock options with a $110.78 exercise price and 970 restricted stock units. The restricted stock units are subject to vesting under the Amended and Restated 2002 Stock Incentive Plan; no Rule 10b5-1 plan is reported. The report also lists direct options over 9,615 common shares at a $57.20 exercise price, expiring July 12, 2027, and 8,641 common shares at $70.37, expiring July 11, 2028.
Paychex Inc. director Joseph Doody reported a transfer of 725 common shares to the Joseph G. Doody Revocable Living Trust on October 16, 2026. On October 15, 2026, he received 970 restricted stock units, subject to vesting under the Amended and Restated 2002 Stock Incentive Plan, and a grant of 4,040 stock options at a $110.78 exercise price. The options have a stated exercise date of October 15, 2027, and expire October 14, 2036.
PAYX VP, Controller & Treasurer Christopher C. Simmons had 38 common shares withheld on October 15, 2026, to satisfy tax obligations arising from the lapse of restrictions on restricted stock units. The reported per-share price was $110.78, and his direct common-stock holdings after the transaction were 3,252 shares.
He also reported six direct stock-option positions: 4,391 underlying shares at $115.00, expiring July 14, 2032; 4,589 at $120.86, expiring July 14, 2033; 1,960 at $117.98, expiring October 14, 2033; 7,145 at $121.63, expiring July 14, 2034; 7,310 at $140.68, expiring July 14, 2035; and 11,082 at $110.00, expiring July 14, 2036.
Paychex Inc. Chairman Martin Mucci received 1,137 restricted stock units on October 15, 2026, subject to vesting under the Amended and Restated 2002 Stock Incentive Plan. He also received 4,735 stock options with a $110.78 exercise price, an exercise date of October 15, 2027, and an expiration date of October 14, 2036. His reported common-stock holdings following the RSU award were 436,028 shares.